GLP-1 receptor agonist drugs as a protective factor against chronic kidney disease in patients with type 2 diabetes mellitus. Research, Society and Development, [S. l.], v. 10, n. 16, p. e134101623517, 2021. DOI: 10.33448/rsd-v10i16.23517. Disponível em: https://rsdjournal.org/rsd/article/view/23517. Acesso em: 5 dec. 2025.